Unknown

Dataset Information

0

Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.

ABSTRACT:

SUBMITTER: Bahiru E 

PROVIDER: S-EPMC6464321 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Fixed-dose combination therapy for the prevention of cardiovascular disease.
| S-EPMC4083498 | biostudies-literature
Unknown Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases.
| S-EPMC7442173 | biostudies-literature
Unknown Exercise versus fixed-dose combination therapy for cardiovascular risk factors control and atherosclerotic disease prevention: a network meta-analysis protocol.
| S-EPMC7348467 | biostudies-literature
Unknown Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases.
| S-EPMC7214354 | biostudies-literature
Unknown Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review.
| S-EPMC9333258 | biostudies-literature
Unknown Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis.
| S-EPMC7957832 | biostudies-literature
Unknown Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.
| S-EPMC4934872 | biostudies-literature
Unknown Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes.
| S-EPMC8096115 | biostudies-literature
Unknown Fixed-dose combination therapy to reduce the growing burden of cardiovascular disease in low- and middle-income countries: feasibility and challenges.
| S-EPMC8031286 | biostudies-literature
Unknown Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date.
| S-EPMC4396584 | biostudies-literature